Pulse Biosciences, Inc. (PLSE)
47.90
-1.93
(-3.87%)
USD |
NASDAQ |
Oct 02, 16:00
47.91
+0.01
(+0.02%)
After-Hours: 20:00
Pulse Biosciences Enterprise Value : 3.296B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.296B |
| October 01, 2026 | 3.433B |
| September 30, 2026 | 3.439B |
| September 29, 2026 | 3.508B |
| September 28, 2026 | 3.609B |
| September 25, 2026 | 3.561B |
| September 24, 2026 | 3.575B |
| September 23, 2026 | 3.585B |
| September 22, 2026 | 3.636B |
| September 21, 2026 | 3.680B |
| September 18, 2026 | 3.719B |
| September 17, 2026 | 3.488B |
| September 16, 2026 | 3.418B |
| September 15, 2026 | 3.813B |
| September 14, 2026 | 3.743B |
| September 11, 2026 | 3.665B |
| September 10, 2026 | 3.759B |
| September 09, 2026 | 3.655B |
| September 08, 2026 | 3.359B |
| September 04, 2026 | 3.675B |
| September 03, 2026 | 3.779B |
| September 02, 2026 | 3.635B |
| September 01, 2026 | 3.593B |
| August 31, 2026 | 3.469B |
| August 28, 2026 | 3.273B |
| Date | Value |
|---|---|
| August 27, 2026 | 3.343B |
| August 26, 2026 | 3.311B |
| August 25, 2026 | 3.374B |
| August 24, 2026 | 3.384B |
| August 21, 2026 | 3.475B |
| August 20, 2026 | 3.293B |
| August 19, 2026 | 3.234B |
| August 18, 2026 | 3.162B |
| August 17, 2026 | 3.218B |
| August 14, 2026 | 3.059B |
| August 13, 2026 | 3.085B |
| August 12, 2026 | 2.972B |
| August 11, 2026 | 3.049B |
| August 10, 2026 | 2.844B |
| August 07, 2026 | 2.908B |
| August 06, 2026 | 2.613B |
| August 05, 2026 | 2.588B |
| August 04, 2026 | 2.608B |
| August 03, 2026 | 2.576B |
| July 31, 2026 | 2.392B |
| July 30, 2026 | 2.386B |
| July 29, 2026 | 2.330B |
| July 28, 2026 | 2.416B |
| July 27, 2026 | 2.227B |
| July 24, 2026 | 2.045B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Lucid Diagnostics, Inc. | 111.17M |
| Accuray, Inc. | 180.04M |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 41.79B |
| Neogen Corp. | 3.272B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.66M |
| Revenue (Quarterly) | 0.434M |
| Total Expenses (Quarterly) | 25.09M |
| EPS Diluted (Quarterly) | -0.3563 |
| Gross Profit Margin (Quarterly) | 37.10% |
| Profit Margin (Quarterly) | -5.68K% |
| Earnings Yield | -2.45% |
| Normalized Earnings Yield | -2.452 |